NEUROBLASTOMA UK
Neuroblastoma UK raises money to fund scientific research into the causes of neuroblastoma (a cancer affecting mainly young children) and improved treatments. It also provides support and advice to parents and others affected by the disease.
Objects
THE RELIEF OF CHILDREN SUFFERING FROM NEUROBLASTOMA
Financial health, per its FY2025 accounts
The accounts state that unrestricted reserves stood at £105,777, which is above the trustees' stated policy target of £70,000. The charity reported a net income of £401,724, driven primarily by donations, while expenditure on charitable activities was significantly lower than the previous year. The independent examiner confirmed that no material matters came to attention during the examination of the accounts.
What the accounts disclose
“Trustees have agreed that £70,000 of reserves must be held (over and above the grant commitments) to support 6 months of operational expenditure.”
Policies the charity declares
- Bullying and harassment policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Investing charity funds policy and procedures
- Investment
- Safeguarding policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Volunteers: 250
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/12/2024
- Volunteers: 4
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/12/2023
- Volunteers: 5
- Grant-making is its main activity
Annual return filing dates (Charity Commission record)
Of its last 5 annual returns with a recorded received date, 1 was received after the due date: year ending 31/12/2024 (received 10/11/2025, 10 days after the 31/10/2025 due date).
In the news
Structured financials (annual return, FY ending 31/12/2023)
Register events
- Received assets from another charity (08/04/2019)
Trustees
- Clair Cliff
- DR Katherine Wheeler
- Dr MARTIN ELLIOTT
- Dr Rebecca Louise Van Goethem
- Faye Watts
- Janet Elizabeth Davies
- Jonathan Anderson
- MALCOLM HUGH DEAN
- PROFESSOR DEBORAH ANNE TWEDDLE
- Ruby Charlotte Dickens
- STEPHEN MICHAEL SMITH
- Victoria Eadington
- Zara Aitchison
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £491k | £89k |
| 31/12/2024 | £303k | £1.2m |
| 31/12/2023 | £665k | £151k |
| 31/12/2022 | £268k | £819k |
| 31/12/2021 | £417k | £122k |
Common questions
Is NEUROBLASTOMA UK financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted reserves stood at £105,777, which is above the trustees' stated policy target of £70,000. The charity reported a net income of £401,724, driven primarily by donations, while expenditure on charitable activities was significantly lower than the previous year. The independent examiner confirmed that no material matters came to attention during the examination of the accounts. Its FY2025 accounts were independently examined.
Who funds NEUROBLASTOMA UK?
Funders whose own accounts filings name NEUROBLASTOMA UK as a grant recipient include Solving Kids' Cancer UK, ROBERT LUFF FOUNDATION LIMITED, THE GROCERS' CHARITY.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| THE IMP TRUST | FY2025 | Unverified read£139k | |
| Solving Kids' Cancer UK | FY2025 | £125k | Co-funding UK sites for the SIOPEN High-Risk Neuroblastoma 2 Trial |
| ROBERT LUFF FOUNDATION LIMITED | FY2025 | £20k | |
| THE GROCERS' CHARITY | FY2025 | £5k | Health |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| SANDRA CHARITABLE TRUST | 2 | £19k |
| THE BUZZACOTT STUART DEFRIES MEMORIAL FUND | 2 | £7k |
| THE HOSPITAL OF GILBERT, EARL OF SHREWSBURY AT SHEFFIELD | 2 | £5k |
| THE OAKDALE TRUST | 2 | £4k |
| CHILDREN WITH CANCER UK | 1 | £375k |
| THE EDWARD GOSTLING FOUNDATION | 1 | £200k |
| MOONDANCE FOUNDATION | 1 | £132k |
| BRAIN TUMOUR RESEARCH | 1 | £128k |
Charities like this
- Solving Kids' Cancer UK
- THE NEUROFIBROMATOSIS ASSOCIATION
- Melanoma UK
- THE AMELIA-MAE FOUNDATION
- THE NEUROSURGICAL FOUNDATION
- SARCOMA UK
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| NEUROBLASTOMA UK | £491k | — | — | unclear | — | no doubt |
| Solving Kids' Cancer UK | £2.9m | — | — | unclear | — | no doubt |
| THE NEUROFIBROMATOSIS ASSOCIATION | £555k | — | 0 | below | 24.1% | no doubt |
| Melanoma UK | £212k | — | 0 | above | 2.3% | no doubt |
| THE AMELIA-MAE FOUNDATION | £116k | — | 0 | above | — | noted |
| THE NEUROSURGICAL FOUNDATION | £95k | — | 0 | above | — | no doubt |